Andreea Seicean
Psychiatry · Rockville, MDNPI 1518354414
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $8,960 of the $14,538 with a category attached, or 61.6%. Johnson & Johnson accounts for 71.0% of it on its own, with 19 other manufacturers making up the rest. Reporting peaked in 2021 at $6,902 and has fallen 81.0% since, to $1,311 in 2025. Among psychiatry clinicians in MD with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 221 payments — averaging $65.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$10K
- AbbVie$806
- Lundbeck LLC$702
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$420
- Corium, LLC$353
- Otsuka America Pharmaceutical, Inc.$309
- plus $2K from 14 others
What the payments were for
- Speaking & faculty fees$8,96062%
- Travel & lodging$7735%
- Food & beverage$4,78533%
- Education$200%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 19 | $10,318 |
| AbbVie(2 entities) | 42 | $806 |
| Lundbeck LLC | 34 | $702 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 21 | $420 |
| Corium, LLC | 19 | $353 |
| Otsuka America Pharmaceutical, Inc. | 14 | $309 |
| Axsome Therapeutics, Inc. | 11 | $304 |
| Novo Nordisk | 7 | $221 |
| Supernus Pharmaceuticals, Inc. | 12 | $219 |
| Tris Pharma Inc | 10 | $196 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $171 |
| Ironshore Pharmaceuticals Inc. | 5 | $119 |
| Collegium Pharmaceutical, Inc. | 5 | $109 |
| Eisai Inc. | 3 | $72 |
| Vertical Pharmaceuticals, LLC | 3 | $64 |
| Noven Therapeutics, LLC | 3 | $58 |
| E.r. Squibb & Sons, L.L.C. | 1 | $30 |
| Neuronetics, Inc. | 2 | $27 |
| Indivior Inc. | 1 | $25 |
| Azurity Pharmaceuticals, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$14,538 in reported general payments places this provider in the 95th percentile of 851 psychiatry providers in Maryland.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RexultiBrexpiprazole | 20 | $33,517 |
| VraylarCariprazine Hcl | 20 | $28,881 |
| TrintellixVortioxetine Hydrobromide | 11 | $10,463 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 69 | $5,247 |
| Lisdexamfetamine Dimesylate | 19 | $3,488 |
| Gabapentin | 47 | $1,835 |
| Lamotrigine | 59 | $1,433 |
| Quetiapine Fumarate | 50 | $743 |
| Modafinil | 30 | $719 |
| Buspirone Hcl | 26 | $712 |
| Clonazepam | 62 | $626 |
| Fluoxetine Hcl | 60 | $537 |
| Methylphenidate Hcl | 22 | $414 |
| Topiramate | 30 | $354 |
| Mirtazapine | 20 | $352 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Otsuka America Pharmaceutical, Inc.Rexulti | $309 | $33,51720 claims |
| AbbVieVraylar | $806 | $28,88120 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix | $171 | $10,46311 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 851 psychiatry providers in Maryland.
Other psychiatry in Rockville
- Thomas LaughrenRockville$283K
- Jay BronderRockville$18K
- Steven IsraelRockville$15K
- Harry Westley ClarkRockville$7K
- John VaethBaltimore$2.1M
- Scott AaronsonBaltimore$334K
- Jamal FawazHagerstown$321K
- Adam RothAnnapolis$210K
- Robert LehmanBaltimore$140K
- Karen AndersonBaltimore$117K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.